Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$219K Sell
4,475
-26,442
-86% -$1.23M ﹤0.01% 1534
2025
Q4
$1.11M Buy
30,917
+14,417
+87% +$584K 0.02% 761
2025
Q3
$747K Buy
+16,500
New +$668K 0.01% 1028

Other funds holding CGNX

Oppenheimer & Co's CGNX Position: Q1 2026 in Review

Oppenheimer & Co reduced its Cognex (CGNX) stake by 86% in Q1 2026, selling an estimated $1.23M and leaving 4,475 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

Oppenheimer & Co first reported a position in CGNX in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.11M in Q4 2025. 570 funds tracked by Wall St. Rank hold CGNX as of Q1 2026.

  • Oppenheimer & Co held 4,475 shares of Cognex worth $219K as of Q1 2026.
  • Oppenheimer & Co sold 26,442 Cognex shares in Q1 2026, an estimated $1.23M.
  • Cognex made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1534 holding.
  • Oppenheimer & Co first reported a position in Cognex in Q3 2025 and has held it in 3 quarters since.
  • Oppenheimer & Co's Cognex position peaked at $1.11M in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Cognex as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.